Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels.

Conditions: Hyperhomocysteinemia Interventions: Dietary Supplement: B-TMG supplementation; Dietary Supplement: B-SAM supplementation; Other: B-TMG placebo; Other: B-SAM placebo Sponsors: S.LAB (SOLOWAYS); Center of New Medical Technologies Recruiting

Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials